Nexalin Technology Announces Additional Positive Clinical Results In Alzheimer’S Disease With Gen-2 Sync Neurostimulation Device
Oct 8 (Reuters) - Nexalin Technology Inc NXL.O:
NEXALIN TECHNOLOGY ANNOUNCES ADDITIONAL POSITIVE CLINICAL RESULTS IN ALZHEIMER’S DISEASE WITH GEN-2 SYNC NEUROSTIMULATION DEVICE
NEXALIN TECHNOLOGY INC - NO ADVERSE EVENTS REPORTED FOR NEXALIN'S DIFS TECHNOLOGY
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.